Teva Pharmaceutical Industries Other Long-Term Assets 2010-2024 | TEVA

Teva Pharmaceutical Industries other long-term assets for the quarter ending September 30, 2024 were $0.459B, a 3.77% decline year-over-year.

  • Teva Pharmaceutical Industries other long-term assets for 2023 were $0.47B, a 6.58% increase from 2022.
  • Teva Pharmaceutical Industries other long-term assets for 2022 were $0.441B, a 14.37% decline from 2021.
  • Teva Pharmaceutical Industries other long-term assets for 2021 were $0.515B, a 4.28% decline from 2020.

Teva Pharmaceutical Industries Other Long-Term Assets 2010-2024 | TEVA

  • Teva Pharmaceutical Industries other long-term assets for 2023 were $0.47B, a 6.58% increase from 2022.
  • Teva Pharmaceutical Industries other long-term assets for 2022 were $0.441B, a 14.37% decline from 2021.
  • Teva Pharmaceutical Industries other long-term assets for 2021 were $0.515B, a 4.28% decline from 2020.